GSP Crop Science Limited
GSP Crop Science Limited (GSPCROP) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
gspcrop.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 270 Cr | 402 Cr | 386 Cr |
| Operating expenses (approx.) | 257 Cr | 366 Cr | 343 Cr |
| EBITDA | 13 Cr | 36 Cr | 43 Cr |
| OPM % | 4.9% | 9.0% | 11.0% |
| Other income | 2 Cr | 9 Cr | 8 Cr |
| Interest | 10 Cr | 10 Cr | 7 Cr |
| Depreciation | 8 Cr | 8 Cr | 9 Cr |
| Profit before tax | -8 Cr | 27 Cr | 35 Cr |
| Tax % | 22.1% | 27.6% | 25.4% |
| Net profit | -6 Cr | 20 Cr | 26 Cr |
| EPS (₹) | ₹-1.38 | ₹5.09 | ₹5.67 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 1,517 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,332 Cr | Sign in for TTM |
| EBITDA | 185 Cr | Sign in for TTM |
| OPM % | 12.2% | Sign in for TTM |
| Other income | 14 Cr | Sign in for TTM |
| Interest | 37 Cr | Sign in for TTM |
| Depreciation | 30 Cr | Sign in for TTM |
| Profit before tax | 127 Cr | Sign in for TTM |
| Tax % | 25.5% | Sign in for TTM |
| Net profit | 95 Cr | Sign in for TTM |
| EPS (₹) | ₹24.93 | Sign in for TTM |
| Dividend payout % | 3.1% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 47 Cr |
| Reserves | 725 Cr |
| Borrowings | 260 Cr |
| Other liabilities | 516 Cr |
| Total liabilities | 1,547 Cr |
| Fixed assets (net) | 215 Cr |
| CWIP | 48 Cr |
| Investments | 16 Cr |
| Loans & advances | 10 Cr |
| Inventories | 356 Cr |
| Trade receivables | 553 Cr |
| Cash & bank | 155 Cr |
| Other assets | 193 Cr |
| Total assets | 1,547 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 59 Cr |
| Cash from investing | -75 Cr |
| Cash from financing | 152 Cr |
| Net cash flow | 137 Cr |
| Free cash flow (OCF − Capex) | -18 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 15.9% |
| ROE % | -0.4% |
| Debtor days | 133 |
| Inventory days | 139 |
| Days payable | 151 |
| Cash conversion cycle | 121 |
| Debt / equity | 0.34 |
| Current ratio | 1.61 |
| Net debt / EBITDA | 0.57 |
Compare with peers
Loading peers…